Compare LyondellBasell Industries NV (LYB) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LyondellBasell Industries NV vs Neurocrine Biosciences Inc — how do they compare? LyondellBasell Industries NV trades at $61.25 (market cap $19.60B), while Neurocrine Biosciences Inc trades at $179 (market cap $17.40B). The key difference: LyondellBasell Industries NV and Neurocrine Biosciences Inc are close in size by market cap, and LyondellBasell Industries NV pays a 6.78% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| LYB | NBIX | |
|---|---|---|
Market Cap | $19.60B | $17.40B |
Sector | Basic Materials | Health |
52-Week High | $82.38 | $180.55 |
52-Week Low | $42.28 | $123.10 |
Enterprise Value | $31.22B | $16.49B |
Dividend Yield | 6.78% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LyondellBasell Industries NV
LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
